Description
No administrar en pacientes con hipersensibilidad al principio activo
OHRENCIA® 125 mg/mL es un medicamento de uso subcutáneo que contiene Abatacept
Profilaxis rutinaria para prevenir sangrados
FENILEFRINA
Caja con 10 tabletas de 600 mg cada una
IPRIKENE 3 G PVO SB 10 VALPROATO DE MAGNESIO 200.00 MG No administrar en pacientes conPRINCIPIO ACTIVO: DIOSMECTITA DOSIS: 3 G FORMA FARMACUTICA: 10 SOBRES POLVO PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
